s6y
Company name or ticker
Search
Maze Therapeutics, Inc.
4
Coloma Jason V: Statement of changes in beneficial ownership of securities
Filed
Friday, October 2, 2026
Period
Oct 1, 2026
Accession number
0001676170-26-000024
Documents
form4-10022026_081010.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header